| MRP | : |
|
| Price | : | ₹10,600.00 |
| You Save | : | ₹18,395.00 (63.44%) |
1 Vial(s) Of 12ml
Bryxta 300mg Injection is an anticancer medication that contains Bevacizumab as its active ingredient. This treatment is designed to inhibit tumor growth. It is prescribed in conjunction with other chemotherapy drugs for the management of metastatic breast cancer, brain cancer, cervical cancer, kidney cancer, lung cancer, and colorectal cancer. Additionally, it is utilized for treating cancers of the ovary, fallopian tube, or primary peritoneal cancer. Effective birth control should be employed during treatment and for at least six months following the final dose. Bryxta 300mg Injection is not advised for adolescents and children under 18 years of age. If you are considering pregnancy soon, consult your doctor regarding the preservation of ovaries, as this medication may lead to fertility issues in women. It is also recommended to refrain from breastfeeding, as this medication may affect growth and development.
Bryxta 300mg Injection is frequently given in combination with other chemotherapy drugs. Common side effects include constipation, loss of appetite, runny nose, fever, skin issues, and weight loss. Prior to commencing treatment with this medication, inform your doctor if you have high blood pressure, elevated blood sugar, gastrointestinal disorders, or heart conditions. This medication should not be administered for 28 days before or after surgery due to its association with poor wound healing and increased bleeding risks. It is advisable to notify your doctor of any dental problems requiring surgery before starting this medication. Should you experience any visual disturbances or confusion, contact your doctor immediately to avoid complications.
Bryxta 300mg Injection is indicated to treat the following conditions:
Bevacizumab is a humanized monoclonal antibody that has been engineered to function as a targeted therapy for the treatment of several advanced cancers. It exerts its effects by specifically binding to a protein known as vascular endothelial growth factor A (VEGF-A), which is found in the lining of blood and lymphatic vessels throughout the body. This action disrupts the interaction between VEGF-A and its receptors, thereby inhibiting the development of blood vessels that provide oxygen and nutrients to tumors. Consequently, it reduces the rate at which cancer progresses.
Bryxta 300 Injection includes 'Bevacizumab', which targets vascular endothelial growth factor (VEGF) present on the surfaces of lymphatic and blood vessels. VEGF promotes the growth of blood vessels within tumors, supplying them with oxygen and nutrients. By inhibiting vascular endothelial growth factor, the supply of oxygen and nutrients to the tumor is restricted, leading to its reduction or halting its growth. Consequently, this aids in the treatment of cancers.
Your doctor or nurse will provide Bryxta 300mg Injection through an intravenous infusion. This infusion must be administered right after the dilution.
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious:
Common:
Breastfeeding - Not Safe
Breastfeeding
Not Safe
It is advised to refrain from breastfeeding for at least 6 months following your treatment with Bryxta 300mg Injection, as this medication may affect your child's growth.
Alcohol - Consult Your Doctor
Alcohol
Consult Your Doctor
Please consult your physician to determine if it is safe to drink alcohol while undergoing treatment with Bryxta 300mg Injection, as there are only limited studies available on this matter.
Liver - Consult Your Doctor
Liver
Consult Your Doctor
Notify your doctor before beginning treatment with Bryxta 300mg Injection if you have any liver conditions to prevent serious side effects.
Lungs - Consult Your Doctor
Lungs
Consult Your Doctor
Make sure to inform your doctor about any lung issues prior to starting treatment with Bryxta 300mg Injection.
Driving - Not Safe
Driving
Not Safe
It is recommended to avoid driving or operating machinery while receiving treatment with Bryxta 300mg Injection, as it may lead to dizziness or drowsiness.
Pregnancy - Not Safe
Pregnancy
Not Safe
Notify your physician before commencing treatment with Bryxta 300mg Injection if you are pregnant or planning to become pregnant, as this medication could potentially harm the unborn child and disrupt blood vessel formation.
Molecule Name: BEVACIZUMAB
Therapeutic Class: Anticancer
Pharmacological Class: VEGF Inhibitor
Indications:
1. Glioblastoma multiforme (brain cancer)
2. Persistent, recurrent, or metastatic breast cancer
3. Metastatic cervical cancer
4. Advanced kidney cancer
5. Metastatic colorectal cancer
6. Advanced non-small-cell lung cancer
7. Liver Cancer- Hepatocellular carcinoma
8. Cancers of the ovary, cervical, fallopian tube, or primary peritoneal cancer
At Medfast, we’re dedicated to bringing you accurate, trustworthy, and expert-vetted health information. Our primary goal is to ensure you receive content that you can rely on.
It’s crucial to understand that everything on this website is for general information purposes only. This content is not a substitute for professional medical advice, diagnosis, or treatment. We can’t stress enough the importance of consulting with your own doctor. They are the only ones who can provide tailored advice for your specific health concerns or medication questions.
Please, never ignore or delay seeking professional medical advice because of something you’ve read here. Our fundamental mission is to support and enhance the doctor-patient relationship, not to replace it.
We maintain strict quality controls on all our partner retailers, so that you always get standard quality products.
100% secure and trusted payment protection
We have a new and dynamic return window policy for medicines and healthcare items. Refer FAQs section for more details.
